BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 17854357)

  • 1. Infliximab-induced acne: report of a third case.
    Sladden MJ; Clarke PJ; Mitchell B
    Br J Dermatol; 2008 Jan; 158(1):172. PubMed ID: 17854357
    [No Abstract]   [Full Text] [Related]  

  • 2. Infliximab-induced acne: report of two cases.
    Bassi E; Poli F; Charachon A; Claudepierre P; Revuz J
    Br J Dermatol; 2007 Feb; 156(2):402-3. PubMed ID: 17223901
    [No Abstract]   [Full Text] [Related]  

  • 3. Induction of pustular lesions during infliximab therapy for Crohn's disease.
    Pérez-Pérez L; Caeiro JL; Fabeiro JM; Allegue F; Zulaica A
    Acta Derm Venereol; 2008; 88(3):292-3. PubMed ID: 18480940
    [No Abstract]   [Full Text] [Related]  

  • 4. Psoriasiform and pustular eruption induced by infliximab.
    Takahashi H; Hashimoto Y; Ishida-Yamamoto A; Ashida T; Kohgo Y; Iizuka H
    J Dermatol; 2007 Jul; 34(7):468-72. PubMed ID: 17584325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberculosis and treatment with infliximab.
    Zhang Z; Correa H; Bégué RE
    N Engl J Med; 2002 Feb; 346(8):623-6. PubMed ID: 11859880
    [No Abstract]   [Full Text] [Related]  

  • 6. [Anti-TNF (infliximab) treatment in Crohn disease: safety profile].
    Carroccio A; Di Prima L; Pirrone G; Ambrosiano G; Noto D; Cefalù AB
    Recenti Prog Med; 2006 Feb; 97(2):108-12; quiz 122. PubMed ID: 16671277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Balancing the risks and benefits of prolonged use of infliximab.
    Schölmerich J
    Gut; 2009 Apr; 58(4):477-8. PubMed ID: 19299379
    [No Abstract]   [Full Text] [Related]  

  • 8. Hidradenitis suppurativa and Crohn's disease: response to treatment with infliximab.
    Martínez F; Nos P; Benlloch S; Ponce J
    Inflamm Bowel Dis; 2001 Nov; 7(4):323-6. PubMed ID: 11720323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute paraplegia after the initiation of anti-tumour necrosis factor-alpha therapy for Crohn's disease.
    Vadikolias K; Kouklakis G; Heliopoulos I; Argyropoulou P; Papanas N; Tzilonidou M; Prassopoulos P; Piperidou H
    Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):159-62. PubMed ID: 17273002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infliximab-induced palmoplantar pustulosis in a patient with crohn disease.
    Sladden MJ; Clarke PJ; Wettenhall J
    Arch Dermatol; 2007 Nov; 143(11):1449. PubMed ID: 18025378
    [No Abstract]   [Full Text] [Related]  

  • 11. Crohn's colitis presenting with node-negative colon cancer and liver metastasis after therapy with infliximab: report of two cases.
    Nicholson T; Orangio GR; Brandenburg D; Wolf DC; Pennington EE
    Dis Colon Rectum; 2005 Aug; 48(8):1651-5. PubMed ID: 15933793
    [No Abstract]   [Full Text] [Related]  

  • 12. Disseminated tuberculosis in a Crohn's disease patient on anti-TNF alpha therapy despite chemoprophylaxis.
    Bourikas LA; Kourbeti IS; Koutsopoulos AV; Koutroubakis IE
    Gut; 2008 Mar; 57(3):425; author reply 425-6. PubMed ID: 18268059
    [No Abstract]   [Full Text] [Related]  

  • 13. Cutaneous Pseudolymphoma in a Patient With Crohn's Disease Under Infliximab: First Report.
    Carvalhana S; Gonçalves A; Velosa J
    J Clin Gastroenterol; 2016; 50(5):436-7. PubMed ID: 26974759
    [No Abstract]   [Full Text] [Related]  

  • 14. Vedolizumab-induced acne in inflammatory bowel disease.
    Gilhooley E; Doherty G; Lally A
    Int J Dermatol; 2018 Jun; 57(6):752-753. PubMed ID: 29654701
    [No Abstract]   [Full Text] [Related]  

  • 15. [Infliximab-induced pustular psoriasis in a patient with Crohn's disease].
    Monteagudo Sánchez B; Cabanillas M; Ortiz-Marin S; Gallego-Ojea JC
    Gastroenterol Hepatol; 2009 Mar; 32(3):175-6. PubMed ID: 19233516
    [No Abstract]   [Full Text] [Related]  

  • 16. Reactivation histoplasmosis after treatment with anti-tumor necrosis factor alpha in a patient from a nonendemic area.
    Jain VV; Evans T; Peterson MW
    Respir Med; 2006 Jul; 100(7):1291-3. PubMed ID: 16545951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of manic switch by the tumour necrosis factor-alpha antagonist infliximab.
    Elisa B; Beny L
    Psychiatry Clin Neurosci; 2010 Aug; 64(4):442-3. PubMed ID: 20653912
    [No Abstract]   [Full Text] [Related]  

  • 18. Infliximab-induced eczematid-like purpura of Doucas and Kapetenakis.
    Wang LC; Medenica MM; Shea CR; Busbey S
    J Am Acad Dermatol; 2003 Jul; 49(1):157-8. PubMed ID: 12833033
    [No Abstract]   [Full Text] [Related]  

  • 19. Onset of flexural psoriasis during infliximab treatment for Crohn's disease.
    Peramiquel L; Puig L; Dalmau J; Ricart E; Roe E; Alomar A
    Clin Exp Dermatol; 2005 Nov; 30(6):713-4. PubMed ID: 16197398
    [No Abstract]   [Full Text] [Related]  

  • 20. Infliximab-induced acne and acute localized exanthematous pustulosis: Case report.
    Senilă S; Seicean A; Fechete O; Grad A; Ungureanu L
    Dermatol Ther; 2017 Nov; 30(6):. PubMed ID: 28976720
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.